Federated Hermes’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-44,807
Closed -$293K 2100
2023
Q4
$293K Sell
44,807
-189,696
-81% -$1.24M ﹤0.01% 1456
2023
Q3
$2.35M Buy
234,503
+22,027
+10% +$220K 0.01% 874
2023
Q2
$2.64M Sell
212,476
-13,148
-6% -$163K 0.01% 869
2023
Q1
$3.16M Sell
225,624
-18,262
-7% -$256K 0.01% 813
2022
Q4
$3.49M Buy
243,886
+186,467
+325% +$2.67M 0.01% 760
2022
Q3
$1.47M Buy
57,419
+21,016
+58% +$537K ﹤0.01% 998
2022
Q2
$1.03M Buy
36,403
+36,036
+9,819% +$1.02M ﹤0.01% 1134
2022
Q1
$13K Sell
367
-23,360
-98% -$827K ﹤0.01% 1867
2021
Q4
$994K Sell
23,727
-63,614
-73% -$2.66M ﹤0.01% 1275
2021
Q3
$4.29M Buy
87,341
+37,599
+76% +$1.85M 0.01% 856
2021
Q2
$2.08M Buy
+49,742
New +$2.08M ﹤0.01% 1083
2021
Q1
Sell
-20,000
Closed -$561K 2310
2020
Q4
$561K Buy
+20,000
New +$561K ﹤0.01% 1497